Top Stories
New therapies and tighter budgets challenge bio/pharma to think outside the industry.
/ read more /
In a $13-billion transaction, GSK will purchase Novartis' share of the Consumer Healthcare Joint Venture.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
INTERPHEX 2018 Keynote Series
Data Integrity Educational Sessions
Experts at INTERPHEX 2018 will discuss regulatory requirements for data integrity and best practices for data integrity and process security.
LEARN MORE
|
|
|
|
Industry News
Major countries will be ranked based on the potential for biopharma market growth, innovation, and competitiveness.
/ read more /
The draft guidance addresses the agency’s policy on evaluating bulk drug substances in drug compounding.
/ read more /
More Industry News
|
|
|
Supplier News
An expanded pharma services supply chain facility in Germany boosts Thermo Fisher’s Pharma Services footprint in Europe.
/ read more /
The CDMO’s new blow-fill-seal machinery at its Kaysersberg site is now operational.
/ read more /
More Supplier News
|
|
|
advertisement
BIO International Convention
BIO International Convention is back in Boston, June 4-7, to celebrate history-making innovation. This is the only event where you can access the global biotech and pharma community via Partnering, attend 150 education sessions and network with 16,000+ attendees from 74 countries. Discover the next generation of cutting-edge products, therapies, and cures at events all week long at BIO 2018.  Learn more at convention.bio.org. |
|
|
Bio/Pharma News
Helsinn will acquire the global rights to Valchlor/Ledaga (mechlorethamine/chlormethine) from Actelion Pharmaceuticals.
/ read more /
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
The agency sent a warning letter to Malladi Drugs & Pharmaceuticals Limited for CGMP violations that include the presence of vermin.
/ read more /
The agency's Committee for Medicinal Products for Human Use recommended six drugs for approval at its March 2018 meeting.
/ read more /
More Regulatory News
|
|
|
|
|
OUTSOURCING
Development and adoption of new technologies create challenges that may take years to resolve.
/ read more /
|
|
|
|
MANUFACTURING
Lower costs, fewer opportunities for temperature excursions, and a smaller carbon footprint are making ocean transport more attractive for pharmaceuticals. Poseidon, a new collaborative pharma initiative, seeks to leverage benefits.
/ read more /
|
|
|
|
FORMULATION
Drug companies must consider all factors impacting the cost of drugs, including high costs of early development stages.
/ read more /
|
|
|
Events
April 2–5, 2018
April 17–19, 2018
April 24–26, 2018
more events |
|
|
eBOOKS
 |
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible. |
|
|
|
|
|
